Perrigo to Separate its Prescription Pharmaceutical Business

 Perrigo to Separate its Prescription Pharmaceutical Business

Perrigo to Separate its Prescription Pharmaceutical Business

Shots:
 
  • Perrigo’s separated business helps it to lead the main focus on consumer business, which includes generic medicines including topical creams, foams, mousses, gels, liquids and inhalable products
  •   It may include a tax-efficient separation to shareholders, a sale or merger with no assurance as to form and timing of transaction
  • This separation of business is expected to complete during H2’19

Click here to read full press release/ article | Ref: Perrigo | Image: Honey Creative

Shiwani Sharma

Shiwani Sharma was Senior Editor at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post